A clinical trial to study the efficacy of single dose of 600 mg of clopidogrel vs two divided doses of 600 mg of clopidogrel.

Efficiency of single dose of 600mg of Clopidogrel vs two divided doses of 600mg of Clopidogrel

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2009/091/000353

Enrollment

100

Registered

2010-08-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- study patients are those who underwent coronary angioplasty for coronary artery disease

Interventions

Intervention1: clopidogrel: 300mg , two doses 12 hours apart Control Intervention1: clopidogrel: 600mg single dose

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients undergoing elective stenting for obstructive coronary artery disease. 2.Age group of 20-70 years.

Exclusion criteria

Exclusion criteria: 1.Known cases of hypersensitivity to clopidogrel 2.Patients simultaneously receiving GP 2a3b inhibitors. 3. Patients with thrombocytopenia or any other hematological abnormality. 4. Patient in cardiogenic shock. 5.Patients unwillingness after randomization

Design outcomes

Primary

Measure	Time frame
All cause death, allergic reactions, haemorraghic bleeding, gastrointestinal bleedsTimepoint: 6 - 12 hours prior to intervention to day one post intervention	—

Secondary

Measure	Time frame
side effect like gastrintestinal and/or nervous and/or allegic manifestationsTimepoint: from 0 hours after drug intake to three days	—

Countries

India

Contacts

Public ContactRNV Narendra Kumar

Additional Prof. Cardiology

mail2jyotsna@rediffmail.com040-23300483

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026